Article thumbnail

PDB26 Evidence Requirements in Australia for Drug Reimbursement: The Survival of Cost Minimisation Analysis

By H. Kim, L. Gurrin and D. Liew
Publisher: International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.
Year: 2012
DOI identifier: 10.1016/j.jval.2012.08.357
OAI identifier:

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.